MatthewBrentLaurensMD

Pediatric Infectious Disease • Baltimore, MD

HIV/AIDS Pediatrics, Pediatric Travel and Tropical Medicine, Pediatric Vaccinology and Vaccine Preventable Diseases

Professor of Pediatrics, Tenured, University of Maryland School of Medicine

Join to view full profile

Dr. Laurens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Laurens' full profile

Already have an account?

Office
22 S Greene St
Baltimore, MD 21201
Phone+1 410-706-5328

Fax+1 410-706-1204

Summary

Dr. Matthew Laurens is a pediatric infectious disease specialist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and University of Maryland Upper Chesapeake Medical Center. He received his medical degree from Mercer University School of Medicine and has been in practice 16 years. He specializes in pediatrics, pediatric travel and tropical medicine, and pediatric vaccinology and vaccine preventable diseases and is experienced in pediatric infectious disease.

Education & Training

University of MarylandFellowship, Pediatric Infectious Diseases, 2005 - 2008
Tulane UniversityResidency, Pediatrics, 2001 - 2005
Mercer University School of MedicineClass of 2001

Certifications & Licensure

MD State Medical License 2005 - 2026
LA State Medical License 2002 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Infectious Diseases

Clinical Trials

Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine Start of enrollment: 2019 Jul 08
Completed
Phase 1

Publications & Presentations

PubMed

Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection.
Andrea A Berry, Thomas L Richie, L W Preston Church, Matthew B Laurens, Colleen Boyce
Malaria Journal. 2025-03-17
Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children.
Nginache Nampota-Nkomba, Osward M Nyirenda, Shrimati Datta, Victoria Mapemba, Priyanka D Patel
Eclinicalmedicine. 2025-03-01
1 citations
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children.
Nginache Nampota-Nkomba, Osward M Nyirenda, Victoria Mapemba, Rhoda Masonga, Priyanka D Patel
Human Vaccines & Immunotherapeutics. 2024-12-31

Press Mentions

Extra Spring COVID Boosters Cleared for Some Americans | HealthApril 21st, 2023
Extra COVID-19 Booster Now Open to Some High-Risk AmericansApril 20th, 2023
FDA Clears Extra COVID Booster for Some High-Risk AmericansApril 19th, 2023
Join now to see all

Grant Support

Safety, immunogencity, and efficacy of PfSPZ LARC2 malaria vaccine in malaria-exposed adults and childrenUNIVERSITY OF MARYLAND BALTIMORE2024–2025